Skip to search formSkip to main contentSkip to account menu

Venous Thrombosis

Known as: Vein thrombosis, Blood clot in vein, Venous Thrombosis [Disease/Finding] 
The formation or presence of a blood clot (THROMBUS) within a vein.
National Institutes of Health

Related topics

Related topics

44 relations
0.2 ML Dalteparin Sodium 25000 UNT/ML Prefilled Syringe0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe0.8 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe5 ML heparin sodium, porcine 10 UNT/ML Prefilled Syringe

Narrower (3)

Deep Vein ThrombosisDeep thrombophlebitisVascular Diseases

Broader (1)

circulatory disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy.
PURPOSE Liver metastases are the principal cause of death in patients with advanced colorectal cancer (CRC). Irinotecan is a… 
Highly Cited
2000
Highly Cited
2000
Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Highly Cited
1998
Highly Cited
1998
Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein Thrombosis
Summary Mild hyperhomocysteinemia is an established risk factor for both arteriosclerosis and thrombosis, and may be caused by… 
Highly Cited
1995
Highly Cited
1995
Paradoxical response to heparin in 10 patients with ulcerative colitis.
OBJECTIVES A patient with ulcerative colitis refractory to standard therapy was treated with heparin for a deep vein thrombosis… 
Highly Cited
1991
Highly Cited
1991
A Randomised Trial of Subcutaneous Low Molecular Weight Heparin (CY 216) Compared with lntravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis
Summary The standard treatment of deep vein thrombosis is given by continuous intravenous infusion of unfractionated heparin… 
Highly Cited
1984
Highly Cited
1984
Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
Human tissue-type plasminogen activator (t-PA), obtained by expression in mammalian cells of recombinant DNA coding for the… 
Highly Cited
1982
Highly Cited
1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
Extrinsic (tissue-type) plasminogen activator (plasminogen activator) was isolated either as a single-chain or as a two-chain… 
Highly Cited
1981
Highly Cited
1981
Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo.
Highly Cited
1976
Highly Cited
1976
EFFICACY OF LOW-DOSE HEPARIN IN PREVENTION OF EXTENSIVE DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING TOTAL-HIP REPLACEMENT
Highly Cited
1968
Highly Cited
1968
Therapeutic defibrination in the treatment of thrombotic disease.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)